GRK5 and non-small cell lung carcinoma: We found that GRK5 is highly expressed in NSCLC cancerous tissues compared with normal non-cancerous tissues, whose high expression in NSCLC patients correlates with worse prognosis and survival rate than low expression patients, and is frequently mutated in NSCLC cancer tissues.